Advances in nanotechnology-enabled drug delivery for combining PARP inhibitors and immunotherapy in advanced ovarian cancer
Advanced ovarian cancer is a malignancy that spreads beyond the ovaries to the pelvis, abdomen, lungs, or lymph nodes. Effective treatment options are available to improve survival rates in patients with advanced ovarian cancer. These include radiation, surgery, chemotherapy, immunotherapy, and tar...
| Autores principales: | , , , |
|---|---|
| Formato: | Artículo |
| Lenguaje: | English |
| Publicado: |
Association of Basic Medical Sciences of Federation of Bosnia and Herzegovina
2024-03-01
|
| Colección: | Biomolecules & Biomedicine |
| Materias: | |
| Acceso en línea: | https://www.bjbms.org/ojs/index.php/bjbms/article/view/9757 |